CytoSorbents Corp. (CTSO)
5.565
+1.04
(+23.12%)
USD |
NASDAQ |
Nov 18, 16:00
5.18
-0.38
(-6.92%)
After-Hours: 20:00
CytoSorbents Enterprise Value : 42.90M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 42.90M |
| November 17, 2026 | 39.61M |
| November 16, 2026 | 40.65M |
| November 13, 2026 | 40.71M |
| November 12, 2026 | 42.29M |
| November 11, 2026 | 42.20M |
| November 10, 2026 | 43.65M |
| November 09, 2026 | 43.74M |
| November 06, 2026 | 40.49M |
| November 05, 2026 | 39.86M |
| November 04, 2026 | 39.74M |
| November 03, 2026 | 39.68M |
| November 02, 2026 | 38.35M |
| October 30, 2026 | 39.68M |
| October 29, 2026 | 39.23M |
| October 28, 2026 | 41.88M |
| October 27, 2026 | 40.65M |
| October 26, 2026 | 39.45M |
| October 23, 2026 | 41.98M |
| October 22, 2026 | 44.31M |
| October 21, 2026 | 42.23M |
| October 20, 2026 | 42.13M |
| October 19, 2026 | 41.00M |
| October 16, 2026 | 38.32M |
| October 15, 2026 | 35.01M |
| Date | Value |
|---|---|
| October 14, 2026 | 35.11M |
| October 13, 2026 | 36.27M |
| October 12, 2026 | 36.68M |
| October 09, 2026 | 37.31M |
| October 08, 2026 | 37.12M |
| October 07, 2026 | 37.56M |
| October 06, 2026 | 37.85M |
| October 05, 2026 | 37.86M |
| October 02, 2026 | 38.13M |
| October 01, 2026 | 38.56M |
| September 30, 2026 | 37.66M |
| September 29, 2026 | 38.14M |
| September 28, 2026 | 38.20M |
| September 25, 2026 | 39.33M |
| September 24, 2026 | 39.08M |
| September 23, 2026 | 41.00M |
| September 22, 2026 | 42.29M |
| September 21, 2026 | 42.88M |
| September 18, 2026 | 43.64M |
| September 17, 2026 | 43.67M |
| September 16, 2026 | 43.58M |
| September 15, 2026 | 44.61M |
| September 14, 2026 | 44.64M |
| September 11, 2026 | 45.71M |
| September 10, 2026 | 45.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 208.41B |
| AngioDynamics, Inc. | 457.01M |
| Alphatec Holdings, Inc. | 1.621B |
| AtriCure, Inc. | 2.733B |
| Baxter International, Inc. | 19.54B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.834M |
| Revenue (Quarterly) | 9.728M |
| Total Expenses (Quarterly) | 11.56M |
| EPS Diluted (Quarterly) | -0.5828 |
| Gross Profit Margin (Quarterly) | 75.33% |
| Profit Margin (Quarterly) | -18.85% |
| Earnings Yield | -96.59% |
| Normalized Earnings Yield | -89.47 |